Europe Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031
Description
Europe Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031
The Europe Anxiety Disorders And Depression Treatment Market would witness market growth of 3.1% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Anxiety Disorders And Depression Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,029.4 million by 2031. The UK market is exhibiting a CAGR of 2.3% during (2024 - 2031). Additionally, The France market would exhibit a CAGR of 3.9% during (2024 - 2031).
The development of new and more effective antidepressants and anxiolytics, with improved safety profiles and fewer side effects, has expanded treatment options for patients. Adopting digital mental health solutions, including mobile therapy and mood-tracking apps, has made treatment more accessible and convenient.
Additionally, many healthcare providers now include mental health screenings as part of routine medical check-ups, which has led to early identification and intervention for anxiety and depression. Programs focusing on early intervention and preventive care have increased the adoption of treatments before conditions become severe.
The rising cases of depression and anxiety among European workers drive companies to implement or expand workplace mental health programs. This creates increased demand for mental health resources, employee assistance programs (EAPs), and counselling services designed to support affected employees. As per the European Council, in 2022, 27% of workers in Europe experienced stress, depression, or anxiety. Additionally, there was a 22% rise in loneliness across the E.U. following the COVID-19 pandemic.
Based on Indication, the market is segmented into Anxiety and Depression. Based on Drugs, the market is segmented into Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Pfizer Inc.
- GlaxoSmithKline PLC (GSK)
- Merck & Co., Inc.
- Eli Lilly And Company
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Johnson & Johnson
- AbbVie Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
By Indication
- Anxiety
- Depression
- Antidepressants
- Anxiolytics
- Anticonvulsants
- Noradrenergic Agents
- Atypical Antipsychotics
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
133 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Anxiety Disorders And Depression Treatment Market, by Indication
- 1.4.2 Europe Anxiety Disorders And Depression Treatment Market, by Drugs
- 1.4.3 Europe Anxiety Disorders And Depression Treatment Market, by Distribution Channel
- 1.4.4 Europe Anxiety Disorders And Depression Treatment Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
- Chapter 4. Europe Anxiety Disorders And Depression Treatment Market by Indication
- 4.1 Europe Anxiety Market by Country
- 4.2 Europe Depression Market by Country
- Chapter 5. Europe Anxiety Disorders And Depression Treatment Market by Drugs
- 5.1 Europe Antidepressants Market by Country
- 5.2 Europe Anxiolytics Market by Country
- 5.3 Europe Anticonvulsants Market by Country
- 5.4 Europe Noradrenergic Agents Market by Country
- 5.5 Europe Atypical Antipsychotics Market by Country
- Chapter 6. Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 6.1 Europe Retail Pharmacies Market by Country
- 6.2 Europe Hospital Pharmacies Market by Country
- 6.3 Europe Online Pharmacies Market by Country
- Chapter 7. Europe Anxiety Disorders And Depression Treatment Market by Country
- 7.1 Germany Anxiety Disorders And Depression Treatment Market
- 7.1.1 Germany Anxiety Disorders And Depression Treatment Market by Indication
- 7.1.2 Germany Anxiety Disorders And Depression Treatment Market by Drugs
- 7.1.3 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.2 UK Anxiety Disorders And Depression Treatment Market
- 7.2.1 UK Anxiety Disorders And Depression Treatment Market by Indication
- 7.2.2 UK Anxiety Disorders And Depression Treatment Market by Drugs
- 7.2.3 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.3 France Anxiety Disorders And Depression Treatment Market
- 7.3.1 France Anxiety Disorders And Depression Treatment Market by Indication
- 7.3.2 France Anxiety Disorders And Depression Treatment Market by Drugs
- 7.3.3 France Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.4 Russia Anxiety Disorders And Depression Treatment Market
- 7.4.1 Russia Anxiety Disorders And Depression Treatment Market by Indication
- 7.4.2 Russia Anxiety Disorders And Depression Treatment Market by Drugs
- 7.4.3 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.5 Spain Anxiety Disorders And Depression Treatment Market
- 7.5.1 Spain Anxiety Disorders And Depression Treatment Market by Indication
- 7.5.2 Spain Anxiety Disorders And Depression Treatment Market by Drugs
- 7.5.3 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.6 Italy Anxiety Disorders And Depression Treatment Market
- 7.6.1 Italy Anxiety Disorders And Depression Treatment Market by Indication
- 7.6.2 Italy Anxiety Disorders And Depression Treatment Market by Drugs
- 7.6.3 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.7 Rest of Europe Anxiety Disorders And Depression Treatment Market
- 7.7.1 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication
- 7.7.2 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs
- 7.7.3 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
- Chapter 8. Company Profiles
- 8.1 Pfizer, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional & Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
- 8.2 GlaxoSmithKline PLC (GSK)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
- 8.3 Merck & Co., Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
- 8.4 Eli Lilly And Company
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 SWOT Analysis
- 8.5 AstraZeneca PLC
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
- 8.6 Bristol-Myers Squibb Company
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
- 8.7 Johnson & Johnson
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental & Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
- 8.8 AbbVie, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 SWOT Analysis
- 8.9 Sanofi S.A.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
- 8.10. Takeda Pharmaceutical Company Limited
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
